RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells
Open Access
- 11 April 2006
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 94 (9) , 1300-1310
Abstract
Silencing those genes that are overexpressed in cancer and contribute to the survival and progression of tumour cells is the aim of several researches. Cyclooxygenase-2 (COX-2) is one of the most intensively studied genes since it is overexpressed in most tumours, mainly in colon cancer. The use of specific COX-2 inhibitors to treat colon cancer has generated great enthusiasm. Yet, the side effects of some inhibitors emerging during long-term treatment have caused much concern. Genes silencing by RNA interference (RNAi) has led to new directions in the field of experimental oncology. In this study, we detected sequences directed against COX-2 mRNA, that potently downregulate COX-2 gene expression and inhibit phorbol 12-myristate 13-acetate-induced angiogenesis in vitro in a specific, nontoxic manner. Moreover, we found that the insertion of a specific cassette carrying anti-COX-2 short hairpin RNA sequence into a viral vector (pSUPER.retro) greatly increased silencing potency in a colon cancer cell line (HT29) without activating any interferon response. Phenotypically, COX-2 deficient HT29 cells showed a significant impairment of their in vitro malignant behaviour. Thus, the retroviral approach enhancing COX-2 knockdown, mediated by RNAi, proved to be an useful tool to better understand the role of COX-2 in colon cancer. Furthermore, the higher infection efficiency we observed in tumour cells, if compared to normal endothelial cells, may disclose the possibility to specifically treat tumour cells without impairing endothelial COX-2 activity.Keywords
This publication has 55 references indexed in Scilit:
- Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cellsJournal of Cancer Research and Clinical Oncology, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Mechanisms of gene silencing by double-stranded RNANature, 2004
- Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interferenceOncogene, 2003
- Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapyThe FASEB Journal, 2003
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumorsOncogene, 2002
- Colocalization Prostacyclin (PGI2) Synthase–Caveolin-1 in Endothelial Cells and New Roles for PGI2 in AngiogenesisExperimental Cell Research, 2001
- Prostacyclin (PGI2) Synthase Is a Constitutively Expressed Enzyme in Human Endothelial CellsExperimental Cell Research, 1995